PharmiWeb.com - Global Pharma News & Resources
21-Feb-2019

Tumor Ablation Market Consumption Volume, Competitive Dynamics And Worldwide Overview 2028

Tumor ablation is technique used in the treatment of tumours in kidney, liver, lungs, and bones. Tumor ablation is considered as a first-line treatment for patients with small hepatocellular carcinomas or benign tumors in liver. In tumor ablation technique, microwave (MW), radio-frequency (RF), high-intensity focused ultrasound (HIFU) systems, or laser is used to heat tissue to at least 60°C for maximum efficacy and cryoablation system is used to cool the tissue to less than −40°C to cause tissue necrosis.

Major factor driving growth of the global tumor ablation market is rising preference for minimal invasive procedures among geriatric population for treatment of various tumors such as lung, kidney, bone, etc. In addition, various advantages of tumor ablation treatment such as easy and fast recovery, minimal or no pain post-surgery, which helps prevent longer stay in hospitals resulting in lower overall treatment expenditure is expected to support growth of the global tumor ablation market.

The global tumor ablation market is segmented into technology, treatment, application, and region.

On the basis of technology, the global tumor ablation market is segmented into radiofrequency ablation (RFA), ethanol (alcohol) ablation, microwave thermotherapy, cryosurgery (cryotherapy). The radiofrequency ablation (RFA) segment is expected to account for highest share in the global tumor ablation market in terms of revenue. This can be attributed to radiofrequency ablation makes use of imaging devices and needle electrode probe to pierce through skin. High frequency currents are passed through electrode for generating heat in order to destroy tumor cells. The microwave thermotherapy segment is projected to register highest CAGR over the forecast period.

On the basis of treatment, the global tumor ablation market is segmented into surgical procedures, laparoscopic procedures and percutaneous procedures. The surgical procedures segment is expected to account for highest share in the global tumor ablation market in terms of revenue. The percutaneous procedures segment is projected to register highest CAGR over the forecast period, this can be attribute to percutaneous procedures involves treating tumors through skin, a small incision is made on skin through which radiofrequency probe is inserted, which terminates the tumor in target tissues.

On the basis of application, the global tumor ablation market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers such as kidney cancer, bone metastasis, and ENT cancer. The liver cancer segment is expected to account for highest share in the global tumor ablation market in terms of revenue. This can be attributed to rising prevalence of lung cancer among individuals. The lung segment is projected to register highest CAGR over the forecast period.

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/tumor-ablation-market/request-sample/

On the basis or region, the global tumor ablation market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East & Africa. North America market accounted for largest market share in the global tumor ablation market. Market in Asia Pacific is expected to register highest CAGR in terms of revenue, owing to increasing patient pool in emerging economies in this region.

Key players operating in the global tumor ablation market include Galil Medical Inc., Misonix Inc., HealthTronics, Inc., AngioDynamics, Inc., Boston Scientific Corporation, Medtronic Plc., SonaCare Medical, LLC, EDAP TMS S.A., and Neuwave Medical Inc.

Editor Details

Last Updated: 21-Feb-2019